1)日本肝移植研究会:肝移植症例登録報告.移植54:81-96,2019
2)Tanabe M, Shimazu M, Wakabayashi G, et al:Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73:1959-1961, 2002
3)Ikegami T, Taketomi A, Soejima Y, et al:Rituximab, IVIG, and plasma exchange without graft local infusion treatment:a new protocol in ABO incompatible living donor liver transplantation. Transplantation 88:303-307, 2009
4)Yoshizawa A, Sakamoto S, Ogawa K, et al:New protocol of immunosuppression for liver transplantation across ABO barrier:the use of Rituximab, hepatic arterial infusion, and preservation of spleen. Transplant Proc 37:1718-1719, 2005
5)Egawa H, Teramukai S, Haga H, et al:Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation:a Japanese multicenter study. Am J Transplant 14:102-114, 2014
6)Raut V, Mori A, Kaido T, et al:Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation 93:99-105, 2012
7)Egawa H, Umeshita K, Uemoto S:Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation. J Hepatobiliary Pancreat Sci 24:89-94, 2017
8)Tajima T, Hata K, Okajima H, et al:Bortezomib against refractory antibody-mediated rejection after ABO-incompatible living-donor liver transplantation:dramatic effect in acute-phase? Transplant Direct 5:e491, 2019
9)Song GW, Lee SG, Hwang S, et al:ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab. Am J Transplant 16:157-170, 2016
10)篠田昌宏,板野 理,尾原秀明,他:慶應義塾大学における成人ABO血液型不適合生体肝移植15年間の成績(解説).今日の移植27:287-290,2014